Molecular Therapy: Oncology Pharmacology (medical)
Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids
The publisher did not provide an abstract — full text is available via the link below.